Safety and dosimetry of 177Lu-rosopatamab tetraxetan plus SoC in patients with metastatic castration-resistant prostate cancer: Preliminary results from part 1 of phase 3 ProstACT Global study.

177Lu-rosopatamab tetraxetan (TLX591) - Telix

enzalutamide - Generic mfg.

docetaxel - Generic mfg.

abiraterone acetate - Generic mfg.

https://www.asco.org/abstracts-presentations/267336

Pedro Barata; Gary Tincknell; David Gill; Simon Fu; Aviral Singh; Alton Sartor; David Cade; Neeraj Agarwal

Apr 21, 2026